Dexcom Inc
Research Dexcom Inc (DXCM) on Bullrun: valuation model: 6.0% undervalued, market cap USD 27.00B, P/E 29.9. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDXCM
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal6.0% undervalued
- Market capUSD 27.00B
- P/E29.9
- Financial periodFY2025
- RevenueUSD 4.66B
- Revenue growth15.6%
- Net incomeUSD 836.30M
- Free cash flowUSD 1.08B
- Gross margin60.1%
Valuation Snapshot
Bullrun's latest valuation model marks Dexcom Inc as 6.0% undervalued; latest market cap is USD 27.00B; P/E is 29.9.
About Dexcom Inc
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions;
Frequently asked questions
Is Dexcom Inc overvalued or undervalued?
Bullrun's valuation model currently marks Dexcom Inc as 6.0% undervalued.
What is Dexcom Inc's market cap?
Dexcom Inc's market capitalization is USD 27.00B.
What is Dexcom Inc's P/E ratio?
Dexcom Inc's price-to-earnings (P/E) ratio is 29.9.
What does Dexcom Inc do?
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally.